Bellevue Group’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$328K Sell
6,803
-138,364
-95% -$9.47M 0.01% 120
2025
Q4
$10.1M Sell
145,167
-170,690
-54% -$6.97M 0.19% 62
2025
Q3
$8.84M Sell
315,857
-32,670
-9% -$651K 0.18% 63
2025
Q2
$7.23M Buy
348,527
+126,812
+57% +$2.79M 0.16% 72
2025
Q1
$3.84M Sell
221,715
-263,335
-54% -$6.45M 0.09% 92
2024
Q4
$13.2M Sell
485,050
-144,708
-23% -$5.13M 0.25% 73
2024
Q3
$27.6M Buy
629,758
+72,437
+13% +$2.8M 0.45% 65
2024
Q2
$21.9M Buy
557,321
+193,395
+53% +$7.94M 0.36% 69
2024
Q1
$15.6M Buy
363,926
+351,626
+2,859% +$14.8M 0.24% 86
2023
Q4
$501K Sell
12,300
-4,500
-27% -$258K 0.01% 135
2023
Q3
$847K Buy
+16,800
New +$541K 0.01% 134

Other funds holding GPCR